James Robinson

James Robinson

Chief Executive Officer bei UROVANT SCIENCES LTD.

54 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

James A.
Robinson
is currently the President, Chief Executive Officer & Director at Urovant Sciences Ltd.
and the Chief Executive Officer & Director at A2 Biotherapeutics, Inc. He is also the Director at The Museum of Science & Industry, the Director at Chicago Horticultural Society, the Director at UroGen Pharma Ltd., the Director at Eledon Pharmaceuticals, Inc., and the Director at Petauri Health LLC.
Additionally, he is a Member of The Commercial Club of Chicago and a Member-Bioscience Council at Chicagonext.
In his former positions, Mr. Robinson served as the President, Chief Executive Officer & Director at Urovant Sciences, Inc. from 2020 to 2023.
He was also the Chief Executive Officer at Qlarity Imaging LLC, a Director at Beacon Therapeutics (USA), Inc. from 2021 to 2022, and a Director at World Business Chicago.
He served as an Independent Director at Neos Therapeutics, Inc. from 2019 to 2021 and held the position of Treasurer & Director at Pharmaceutical Research & Manufacturers of America in 2018.
He was the President & Chief Operating Officer at Alkermes, Inc. from 2005 to 2019 and the President at Astellas Pharma US, Inc. from 2013 to 2016.
He later became the President at Astellas US LLC from 2016 to 2018 and the President & Chief Operating Officer at Alkermes Plc from 2018 to 2019.
Prior to that, he was the Vice President-Hepatitis Sales & Managed Care at Schering-Plough Corp.
from 1992 to 2002.
He also served as a Director & Founding Member at Innovation Development Institute, Inc. Mr. Robinson obtained his undergraduate degree from DePaul University in 1992.

Aktive Positionen von James Robinson

UnternehmenPositionBeginn
UROVANT SCIENCES LTD. Chief Executive Officer 23.03.2020
UROGEN PHARMA LTD. Director/Board Member 25.07.2023
ELEDON PHARMACEUTICALS, INC. Director/Board Member 01.10.2023
Chief Executive Officer 01.04.2024
Director/Board Member -
Director/Board Member -
Chicagonext Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
Alle aktiven Positionen von James Robinson

Ehemalige bekannte Positionen von James Robinson

UnternehmenPositionEnde
░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von James Robinson im Detail an

Ausbildung von James Robinson

DePaul University Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von James Robinson im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

23

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
UROGEN PHARMA LTD.

Health Technology

ELEDON PHARMACEUTICALS, INC.

Health Technology

ALKERMES PLC

Health Technology

Private Unternehmen19

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Chicagonext

Electronic Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Services

Technology Services

Consumer Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. James Robinson